EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies

Natalia Nosalova iD, Mykhailo Huniadi, Ľubica Horňáková iD, Alexandra Valenčáková iD, Slavomir Horňák, Kamil Nagoos, Juraj Vozar, Dasa Cizkova iD

International Journal of Molecular Sciences · 01.03.2024 · 25 (5) · 2891

DOI: 10.3390/ijms25052891 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.03.2024. Verfasst von Natalia Nosalova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Small Animal Clinic, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 041 81 Kosice, Slovakia. Hauptthemen laut MEDLINE: Mammary Neoplasms, Animal, Breast Neoplasms, Dog Diseases. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VEGA, Slovak Research and Development Agency, APVV.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, many studies have focused their attention on the dog as a proper animal model for human cancer. In dogs, mammary tumors develop spontaneously, involving a complex interplay between tumor cells and the immune system and revealing several molecular and clinical similarities to human breast cancer. In this review, we summarized the major features of canine mammary tumor, risk factors, and the most important biomarkers used for diagnosis and treatment. Traditional therapy of mammary tumors in dogs includes surgery, which is the first choice, followed by chemotherapy, radiotherapy, or hormonal therapy. However, these therapeutic strategies may not always be sufficient on their own; advancements in understanding cancer mechanisms and the development of innovative treatments offer hope for improved outcomes for oncologic patients. There is still a growing interest in the use of personalized medicine, which should play an irreplaceable role in the research not only in human cancer therapy, but also in veterinary oncology. Moreover, immunotherapy may represent a novel and promising therapeutic option in canine mammary cancers. The study of novel therapeutic approaches is essential for future research in both human and veterinary oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mammary Neoplasms, AnimalBreast NeoplasmsDog DiseasesDogsHumansAnimalsFemaleBiomarkersImmunotherapy

Stichwörter der Autor:innen

biomarkerscanine mammary tumorpersonalized medicinetreatment

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Small Animal Clinic, University of Veterinary Medicine and Pharmacy, Komenskeho 73, 041 81 Kosice, Slovakia.

ORCID-Profile: Natalia Nosalova, Ľubica Horňáková, Alexandra Valenčáková, Dasa Cizkova

Förderung

  • VEGA
  • Slovak Research and Development Agency
  • APVV

Zitieren

APA

Nosalova, N., Huniadi, M., Horňáková, Ľ., Valenčáková, A., Horňák, S., Nagoos, K., Vozar, J., & Cizkova, D. (2024). Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies. International Journal of Molecular Sciences, 25(5), 2891. https://doi.org/10.3390/ijms25052891

Vancouver

Nosalova N, Huniadi M, Horňáková Ľ, Valenčáková A, Horňák S, Nagoos K, et al. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies. International Journal of Molecular Sciences. 2024;25(5):2891. doi:10.3390/ijms25052891

BibTeX
@article{Nosalova2024,
  author = {Nosalova, Natalia and Huniadi, Mykhailo and Horňáková, Ľubica and Valenčáková, Alexandra and Horňák, Slavomir and Nagoos, Kamil and Vozar, Juraj and Cizkova, Dasa},
  title = {Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {5},
  pages = {2891},
  doi = {10.3390/ijms25052891}
}
Kostenlos starten →